Open Access Open Access  Restricted Access Subscription Access

Causes, Symptoms, Intellectual Disability, Behavioural Issues, Skin Conditions, Microcephaly, Seizures, Management, Regular Monitoring, Nutrition a Supplementation, Support As Well As Counselling of Classical PKD and Symptoms, Treatment As Well As Managem

Mohan Naidu .K, Muralinath .E, Amrutham Sandeep, Vinayasree .C, Venkat Naveen . A, Guruprasad .M, Sravani Pragna .K

Abstract


Phenylketonuria (PKU) is a genetic disorder with an incidence of approximately 1 in 10,000 to 15,000 births worldwide. Phenylketonuria is an inherited metabolic disorder manifested by the lack  of  ability to metabolize phenylalanine, an amino acid found in many protein-rich foods. This review provides a detailed overview of PKU, including its types, clinical manifestations, and management strategies. The understanding of PKU has developed  over the years, leading to improved diagnosis and treatment approaches. Early detection and intervention play a crucial role in obstructing  intellectual disabilities and ensuring a better quality of life for individuals with PKU.


Full Text:

PDF

References


Williams RA, Mamotte CD, Burnett JR. Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev. 2008 Feb;29(1):31-41. [PMC free article] [PubMed]

Flydal MI, Martinez A. Phenylalanine hydroxylase: function, structure, and regulation. IUBMB Life. 2013 Apr;65(4):341-9. [PubMed]

Michals-Matalon K, Bhatia G, Guttler F, Tyring SK, Matalon R. Response of phenylketonuria to tetrahydrobiopterin. J Nutr. 2007 Jun;137(6 Suppl 1):1564S-1567S; discussion 1573S-1575S. [PubMed]

Christ SE, Moffitt AJ, Peck D, White DA. The effects of tetrahydrobiopterin (BH4) treatment on brain function in individuals with phenylketonuria. Neuroimage Clin. 2013;3:539-47. [PMC free article] [PubMed]

Prick BW, Hop WC, Duvekot JJ. Maternal phenylketonuria and hyperphenylalaninemia in pregnancy: pregnancy complications and neonatal sequelae in untreated and treated pregnancies. Am J Clin Nutr. 2012 Feb;95(2):374-82. [PubMed]

Chandler RJ, Venditti CP. Gene Therapy for Metabolic Diseases. Transl Sci Rare Dis. 2016;1(1):73-89. [PMC free article] [PubMed]

Hofman DL, Champ CL, Lawton CL, Henderson M, Dye L. A systematic review of cognitive functioning in early treated adults with phenylketonuria. Orphanet J Rare Dis. 2018 Aug 30;13(1):150. [PMC free article] [PubMed]


Refbacks

  • There are currently no refbacks.